Warren Hamel and Maggie Grace published "The Fourth Circuit Limits FCA Liability in cGMP Cases" in Bloomberg BNA's Pharmaceutical Law & Industry Report on April 18, 2014.
Click to view "The Fourth Circuit Limits FCA Liability in cGMP Cases."
April 18, 2014 | Bloomberg BNA's Pharmaceutical Law & Industry Report
The Fourth Circuit Limits FCA Liability in cGMP Cases
1 min
Related Services
Practices
Related Insights
Life Sciences Anti-Corruption Enforcement Trends to Watch
Life Sciences Anti-Corruption Enforcement Trends to Watch
August 27, 2021
1min
Global Anti-Corruption Enforcement in the Life Sciences Industry: Trends, Risks & Best Practices in 2021
Global Anti-Corruption Enforcement in the Life Sciences Industry: Trends, Risks & Best Practices in 2021
August 26, 2021
1min
Congress Passes Corporate Transparency Act Creating Expansive Beneficial Ownership Registry with Significant Implications for U.S. and Foreign Business
Congress Passes Corporate Transparency Act Creating Expansive Beneficial Ownership Registry with Significant Implications for U.S. and Foreign Business
December 15, 2020
6min
Recent News
Bloomberg Law Quotes Jonathan Pompan on the CFPB's Coming Fight Before the Ninth Circuit
Bloomberg Law Quotes Jonathan Pompan on the CFPB's Coming Fight Before the Ninth Circuit
September 23, 2021
1min
Venable Shows Another Strong Year in 2021 AmLaw Global 100
Venable Shows Another Strong Year in 2021 AmLaw Global 100
September 23, 2021
1min
Profiles in Diversity Journal Recognizes Stacie Tobin Among Its 2021 Women Worth Watching in Leadership
Profiles in Diversity Journal Recognizes Stacie Tobin Among Its 2021 Women Worth Watching in Leadership
September 22, 2021
2min